Omegaven (w-3 Fish Oil) Supplemented Parenteral Nutrition in Subjects of SICU.
NCT00172198
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Critical Ill Patients in SICU
Interventions
DRUG:
Omegaven 10%
Sponsor
National Taiwan University Hospital